{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:25:42Z","timestamp":1784093142173,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572242"],"award-info":[{"award-number":["81572242"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81228013"],"award-info":[{"award-number":["81228013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Key Lab of Human Sport Competence Development and Maintenance","award":["11DZ2261100"],"award-info":[{"award-number":["11DZ2261100"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1107828"],"award-info":[{"award-number":["APP1107828"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cgfr.co.uk","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cytogfr.2016.10.002","type":"journal-article","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T14:50:27Z","timestamp":1476197427000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Molecular structure and differential function of choline kinases CHK\u03b1 and CHK\u03b2 in musculoskeletal system and cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Xi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tickner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2016.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1194\/jlr.R700019-JLR200","article-title":"Phosphatidylcholine and choline homeostasis","volume":"49","author":"Li","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/153537020623100503","article-title":"Choline transport for phospholipid synthesis","volume":"231","author":"Michel","year":"2006","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1023\/A:1022809003997","article-title":"High-affinity choline transporter","volume":"28","author":"Okuda","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/187152412800792733","article-title":"The ubiquitous choline transporter SLC44A1","volume":"12","author":"Michel","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.plipres.2003.12.001","article-title":"Structure and function of choline kinase isoforms in mammalian cells","volume":"43","author":"Aoyama","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1139\/O09-160","article-title":"Choline kinase and its function","volume":"88","author":"Wu","year":"2010","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0022-2275(20)34484-9","article-title":"Structure and characterization of the genes for murine choline\/ethanolamine kinase isozymes alpha and beta","volume":"41","author":"Aoyama","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbalip.2006.01.005","article-title":"Deletion and alanine mutation analyses for the formation of active homo- or hetero-dimer complexes of mouse choline kinase-alpha and -beta","volume":"1761","author":"Liao","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0045","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1074\/jbc.M708766200","article-title":"Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis","volume":"283","author":"Wu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.biocel.2008.01.013","article-title":"Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy","volume":"40","author":"Ramirez de Molina","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0055","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1158\/0008-5472.CAN-05-1807","article-title":"RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation","volume":"65","author":"Glunde","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.advenzreg.2010.09.010","article-title":"Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions","volume":"51","author":"Gallego-Ortega","year":"2011","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1470-2045(07)70279-6","article-title":"Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study","volume":"8","author":"Ramirez de Molina","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0070","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/oncsis.2013.2","article-title":"A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival","volume":"2","author":"Falcon","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0075","doi-asserted-by":"crossref","first-page":"e0141110","DOI":"10.1371\/journal.pone.0141110","article-title":"Downregulation of choline kinase-alpha enhances autophagy in tamoxifen-resistant breast cancer cells","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0080","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/onc.2014.462","article-title":"Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition","volume":"34","author":"Bonora","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0085","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/nbm.3429","article-title":"Choline kinase-alpha protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival","volume":"28","author":"Mori","year":"2015","journal-title":"NMR Biomed."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv371","article-title":"Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target","volume":"108","author":"Asim","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0095","first-page":"335","article-title":"Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer","volume":"29","author":"Gallego-Ortega","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/14737159.2015.1039515","article-title":"Choline metabolism-based molecular diagnosis of cancer: an update","volume":"15","author":"Glunde","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2016.03.005","article-title":"Choline kinase alpha-putting the ChoK-hold on tumor metabolism","volume":"63","author":"Arlauckas","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0115","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1074\/jbc.M512578200","article-title":"A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis","volume":"281","author":"Sher","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbalip.2009.02.006","article-title":"Understanding the muscular dystrophy caused by deletion of choline kinase beta in mice","volume":"1791","author":"Wu","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneurol.2011.2333","article-title":"Congenital megaconial myopathy due to a novel defect in the choline kinase beta gene","volume":"69","author":"Gutierrez Rios","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ng.231","article-title":"Variant between CPT1B and CHKB associated with susceptibility to narcolepsy","volume":"40","author":"Miyagawa","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e328364c82d","article-title":"Megaconial congenital muscular dystrophy due to loss-of-function mutations in choline kinase beta","volume":"26","author":"Mitsuhashi","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.5692\/clinicalneurol.53.1112","article-title":"New congenital muscular dystrophy due to CHKB mutations","volume":"53","author":"Nishino","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ejpn.2014.06.005","article-title":"Exome sequencing identifies a CHKB mutation in Spanish patient with megaconial congenital muscular dystrophy and mtDNA depletion","volume":"18","author":"Castro-Gago","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.braindev.2015.05.008","article-title":"Congenital neurogenic muscular atrophy in megaconial myopathy due to a mutation in CHKB gene","volume":"38","author":"Castro-Gago","year":"2016","journal-title":"Brain Dev."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0155","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.bbagen.2014.03.008","article-title":"Choline kinase beta is required for normal endochondral bone formation","volume":"1840","author":"Li","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0160","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1074\/jbc.M114.567966","article-title":"Choline kinase beta mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass","volume":"290","author":"Kular","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1074-7613(01)00199-6","article-title":"Genome-wide ENU mutagenesis to reveal immune regulators","volume":"15","author":"Nelms","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1359\/jbmr.070108","article-title":"Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization","volume":"22","author":"Roberts","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20040511","article-title":"Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities","volume":"382","author":"Roberts","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0180","doi-asserted-by":"crossref","first-page":"C693","DOI":"10.1152\/ajpcell.00251.2007","article-title":"Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts","volume":"294","author":"Okamoto","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S1464793103006262","article-title":"Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption","volume":"79","author":"Zaidi","year":"2004","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbrc.2007.09.137","article-title":"RANKL-induced down-regulation of CX3CR1 via PI3K\/Akt signaling pathway suppresses fractalkine\/CX3CL1-induced cellular responses in RAW264.7 cells","volume":"364","author":"Saitoh","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.onc.1205144","article-title":"Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K","volume":"21","author":"Ramirez de Molina","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0205","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1038\/cddis.2013.453","article-title":"Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells","volume":"4","author":"Sanchez-Lopez","year":"2013","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1535-7163.MCT-15-0214","article-title":"Choline kinase alpha (CHKalpha) as a therapeutic target in pancreatic ductal adenocarcinoma: expression, predictive value, and sensitivity to inhibitors","volume":"15","author":"Mazarico","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/med.2610140503","article-title":"Structure-activity aspects of hemicholinium-3 (HC-3) and its analogs and congeners","volume":"14","author":"Cannon","year":"1994","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0220","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.1074\/jbc.M109.039024","article-title":"Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0225","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1038\/onc.2011.51","article-title":"A novel small molecule antagonist of choline kinase-alpha that simultaneously suppresses MAPK and PI3K\/AKT signaling","volume":"30","author":"Clem","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/bcj.2015.10","article-title":"Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-alpha and therapeutic targeting","volume":"5","author":"Xiong","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acs.jmedchem.5b01552","article-title":"Novel small molecule inhibitors of choline kinase identified by fragment-based drug discovery","volume":"59","author":"Zech","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0240","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1991.tb12471.x","article-title":"Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice","volume":"104","author":"Gimenez","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1101\/lm.83905","article-title":"Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats","volume":"12","author":"Teather","year":"2005","journal-title":"Learn. Mem."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0250","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1179\/1743132811Y.0000000004","article-title":"CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves","volume":"33","author":"Aslan","year":"2011","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1179\/1743132812Y.0000000003","article-title":"Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury","volume":"34","author":"Caner","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0260","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jss.2015.10.003","article-title":"CDP-choline modulates matrix metalloproteinases in rat sciatic injury","volume":"200","author":"Gundogdu","year":"2016","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jss.2012.11.032","article-title":"CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis","volume":"183","author":"Cetinkaya","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/pr.2013.68","article-title":"Cytidine 5\u2032-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model","volume":"74","author":"Cetinkaya","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1358\/mf.1999.21.9.795632","article-title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer\u2019s disease patients Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","volume":"21","author":"Alvarez","year":"1999","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1468-1331.2008.02099.x","article-title":"Cytidine-5\u2032-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy","volume":"15","author":"Parisi","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0285","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/0269881114553254","article-title":"CDP-choline: effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression","volume":"28","author":"Knott","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2015.02.032","article-title":"Effects of acute CDP-choline treatment on resting state brain oscillations in healthy volunteers","volume":"591","author":"Knott","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0295","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14656560902765652","article-title":"Efficacy of citicoline as an acute stroke treatment","volume":"10","author":"Clark","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(99)00660-6","article-title":"Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats","volume":"273","author":"Gimenez","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0310","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mito.2016.02.001","article-title":"Megaconial muscular dystrophy caused by mitochondrial membrane homeostasis defect, new insights from skeletal and heart muscle analyses","volume":"27","author":"Vanlander","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1139\/o03-074","article-title":"Cell biology of cardiac mitochondrial phospholipids","volume":"82","author":"Hatch","year":"2004","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0320","doi-asserted-by":"crossref","first-page":"187071","DOI":"10.1155\/2014\/187071","article-title":"Pre-conditioning with CDP-choline attenuates oxidative stress-induced cardiac myocyte death in a hypoxia\/reperfusion model","volume":"2014","author":"Gonzalez-Pacheco","year":"2014","journal-title":"Sci.World J."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0325","first-page":"316","article-title":"Mortality outcomes after osteoporotic fractures in men and women","volume":"33","author":"Iacovino","year":"2001","journal-title":"J. Insur. Med."},{"key":"10.1016\/j.cytogfr.2016.10.002_bib0330","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: scientific review","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610116301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T07:51:19Z","timestamp":1692517879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610116301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":66,"alternative-id":["S1359610116301095"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.10.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular structure and differential function of choline kinases CHK\u03b1 and CHK\u03b2 in musculoskeletal system and cancer","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2016.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}